Differential expression of estrogen receptor-α and -β messenger RNAs as a potential marker of ovarian carcinogenesis

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5367-5373

  Pujol, Pascal ^a,b   Rey, Jean Marc ^a,b   Nirde, Philippe ^b   Roger, Pascal ^b   Gastaldi, Marguerite ^c   Laffargue, François ^a   Rochefort, Henri ^a,b   Maudelonde, Thierry ^a,b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b INSERM   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN RECEPTOR; MESSENGER RNA; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; EPITHELIUM TUMOR; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY;

DISEASE PROGRESSION; DNA, COMPLEMENTARY; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IN SITU HYBRIDIZATION; OVARIAN DISEASES; OVARIAN NEOPLASMS; PLASMIDS; PROTEIN ISOFORMS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032401855     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer statistics. CA Cancer J. Clin., 44: 7-26, 1994.
2. Katso, R. M., Manek, S., O'Byrne, K., Playford, M. P., Le Meuth, V., and Ganesan, T. S. Molecular approaches to diagnosis and management of ovarian cancer. Cancer Metastasis Rev., 16: 81-107, 1997.
3. Godwin, A. K., Perez, R. P., Johnson, S. W., Hamaguchi, K., and Hamilton, T. C. Growth regulation of ovarian cancer. Hematol. Oncol. Clin. N. Am., 6: 829-841, 1992.
4. Clinton, G. M., and Hua, W. Estrogen action in human ovarian cancer. Crit. Rev. Oncol. Hematol., 25: 1-9, 1997.
5. Lantta, M. Estradiol and progesterone receptors in normal ovary and ovarian tumors. Acta Obstet. Gynecol. Scand., 63: 497-503, 1984.
6. Bergqvist, A., Kullander, S., and Thorell, J. A study of estrogen and progesterone cytosol receptor concentration in benign and malignant ovarian tumors and a review of malignant ovarian tumors treated with medroxy-progesterone acetate. Acta. Obstet. Gynecol. Scand. Suppl., 101: 75-81, 1981.
7. Willcocks, D., Toppila, M., Hudson, C. N., Tyler, J. P. P., Baird, P. J., and Eastman, C. J. Estrogen and progesterone receptors in human ovarian tumors. Gynecol. Oncol., 16: 246-253, 1983.
8. Vierikko, P., Kauppila, A., and Vihko, R. Cytosol and nuclear estrogen and progestin receptors and 17beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary. Int. J. Cancer, 32: 413-422, 1983.
9. Toppila, M., Tyler, J. P. P., Fay, R., Baird, P. J., Crandon, A. J., Eastman, C. J., and Hudson, C. N. Steroid receptors in human ovarian malignancy. A review of four years tissue collection. Br. J. Obstet. Gynaecol., 93: 986-992, 1986.
10. Rao, B. R., and Slotman, B. J. Endocrine factors in common epithelial ovarian cancer. Endocr. Rev., 12: 14-26, 1991.
11. Mosselman, S., Polman, J., and Dijkema, R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett., 392: 49-53, 1996.
12. Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J. A. Comparision of the ligand binding specificity and transcription tissue distribution of estrogen receptors a and β. Endocrinology, 138: 863-870, 1997.
13. Byers, M., Kuiper, G. J., Gustafsson, J. A., and Park-sarge, O. K. Estrogen receptor-β mRNA. Expression in rat ovary: down-regulation by gonadotropins. Mol. Endocrinol., 11: 172-182, 1997.
14. Enmark, E., Pelto-huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjold, M., and Gustafsson, J. A. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab., 82: 4258-4264, 1997.
15. Brandenberger, A. W., Kian Tee, M., Lee, J. Y., Chao, V., and Jaffe R. B. Tissue distribution of oestrogen receptors α (ER-α) and β (ER-β) mRNA in the midgestational human fetus. J. Clin. Endocrinol. Metab., 82: 3509-3512, 1997.
16. Brandenberger, A. W., Tee, M. K., and Jaffe R. B. Estrogen receptor α (ERα) and β (ERβ) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ERβ in neoplastic tissues. J Clin. Endocrinol. Metab., 83: 1025-1028, 1998.
17. Lemieux, P., and Fuqua, S. A. W. The role of estrogen receptor in tumor progression. J. Steroid Biochem., 56: 87-91, 1996.
18. Osborne, C. K., Yochmowitz, M. G., Knight, W. A., and McGuire, W. L. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer (Phila.), 46: 2884-2888, 1980.
19. Freiss, G., Puech, C., and Vignon, F. Extinction of IGF-1 mitogenic signaling by antiestrogen-stimulated Fas-associated protein tyrosine phosphatase-1 in human breast cancer cells. Mol. Endocrinol. 12: 568-579, 1998.
20. Ponglikitmongkol, M., Green, S., and Chambon, P. Genomic organisation of the human oestrogen receptor gene. EMBO J., 7: 3385-3388, 1988.
21. Nirde, P., Georget, V., Terouanne, B., Galifer, R. B., Belon, C., and Sultan, C. Quantitation of androgen receptor messenger RNA from genital skin fibroblasts by reverse transcription-competitive polymerase chain reaction. J. Steroid Biochem. Mol. Biol., 66: 35-43, 1998.
22. Spector, D. L., Goldman, R. D., and Leinwand, L. A. In: D. L. Spector (ed.), In situ Hybridization to RNA Cells: Subcellular localization of gene and their products. A Laboratory Manual, Ed. 2., pp. 116.1-116.16. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
23. Roger, P., Pujol, P., Lucas, A., Baldet, P., and Rochefort, H. Increased immunostaining of Fibulin-1 and estrogen regulated protein in the stroma of human ovarian epithelial tumors. Am. J. Pathol., in press, 1998.
24. Mazars, R., Pujol, P., Maudelonde, T., Jeanteur, P., and Theillet, C. P53 mutations in ovarian cancer: a late event? Oncogene, 6: 1685-1690, 1991.
25. Tibiletti, M. G., Trubia, M., Ponti, E., Sessa, L., Acquati, F., Furlan, D., Bernasconi, B., Fichera, M., Mihalich, A., Ziegler, A., Volz, A., Facco, C., Riva, C., Cremonesi, L., Ferrari, M., and Taramelli, T. Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involvement in benign surface epithelial ovarian tumors. Oncogene, 16: 1639-1642, 1998.
26. Saretzki, G., Hoffmann, U., Röhlke, P., Psille, R., Gaigal, T., Keller, G., Höfler, H., Löning, T., Petersen, I., and Dietel, M. Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome. Cancer (Phila.), 80: 1241-1249, 1997.
27. Scambia, G., Benedetti-Panici, P., Ferrandina, G., Distefano, M., Salerno, G., Romanini, M. E., Fagotti, A., and Mancuso, S. Epidermal growth factor estrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy. Br. J. Cancer, 72: 361-366, 1995.
28. Hatch, K. D., Beecham, J. B., Blessing, J. A., and Creasman, W. T. Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. Cancer (Phila.), 68: 269-271, 1991.
29. Korach, K. S. Insights from the study of animals lacking functional estrogen receptor. Science (Washington DC), 266: 1524-1527, 1994.
30. Couse, J. F., Lindzey, J., Grandien, K., Gustafsson, J. A., and Korach, K. S. Tissue distribution and quantitative analysis of estrogen receptor-α (ER-α) and estrogen receptor-β (ER-β) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology, 138: 4613-4621, 1997.